In interaction with gender a common CYP3A4 polymorphism may influence the survival rate of chemotherapy for childhood acute lymphoblastic leukemia

CYP3A4 has an important role in the metabolisms of many drugs used in acute lymphoblastic leukemia (ALL) therapy; still, there are practically no publications about the role of CYP3A4 polymorphisms in ALL pharmacogenomics. We genotyped eight common single-nucleotide polymorphisms (SNPs) in the CYP3A4 and CYP3A5 genes in 511 children with ALL and investigated whether they influenced the survival of the patients. We involved additional 127 SNPs in 34 candidate genes and searched for interactions with respect to the survival rates. Significant association between the survival rates and the common rs2246709 SNP in the CYP3A4 gene was observed. The gender of the patients and the rs1076991 in the MTHFD1 gene strongly influenced this effect. We calculated new risk assessments involving the gender-rs2246709 interaction and showed that they significantly outperformed the earlier risk-group assessments at every time point. If this finding is confirmed in other populations, it can have a considerable prognostic significance.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  Christine Sinoquet,et al.  Probabilistic graphical models for genetics, genomics and postgenomics , 2014 .

[3]  A. Dreher.  Modeling Survival Data Extending The Cox Model , 2016 .

[4]  H. Sharafi,et al.  Association of -24CT, 1249GA, and 3972CT ABCC2 Gene Polymorphisms with Methotrexate Serum Levels and Toxic Side Effects in Children with Acute Lymphoblastic Leukemia , 2014, Pediatric hematology and oncology.

[5]  C. Thangavel,et al.  Intrinsic sexually dimorphic expression of the principal human CYP3A4 correlated with suboptimal activation of GH/glucocorticoid-dependent transcriptional pathways in men. , 2011, Endocrinology.

[6]  Matthew N. Davies,et al.  Bioinformatics for immunomics , 2010 .

[7]  Hongbing Wang,et al.  The effect of cyclophosphamide with and without dexamethasone on cytochrome P450 3A4 and 2B6 in human hepatocytes. , 2002, Drug metabolism and disposition: the biological fate of chemicals.

[8]  D. Gómez-Almaguer,et al.  Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia? , 2011, Pediatric blood & cancer.

[9]  Peter Antal,et al.  A Bioinformatic Platform for a Bayesian, Multiphased, Multilevel Analysis in Immunogenomics , 2009 .

[10]  A. Falus,et al.  Candidate gene association study in pediatric acute lymphoblastic leukemia evaluated by Bayesian network based Bayesian multilevel analysis of relevance , 2012, BMC Medical Genomics.

[11]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[12]  M. Krajinovic,et al.  Pharmacogenomics of acute leukemia. , 2007, Pharmacogenomics.

[13]  U. Fuhr,et al.  Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. , 2001, International journal of clinical pharmacology and therapeutics.

[14]  Leming Shi,et al.  Sex Differences in the Expression of Drug-Metabolizing and Transporter Genes in Human Liver , 2012, Journal of drug metabolism & toxicology.

[15]  A. Falus,et al.  Evaluation of a Partial Genome Screening of Two Asthma Susceptibility Regions Using Bayesian Network Based Bayesian Multilevel Analysis of Relevance , 2012, PloS one.

[16]  A. Paterson,et al.  Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method. , 2000, Pharmacogenetics.

[17]  D. Waxman,et al.  Sex Differences in the Expression of Hepatic Drug Metabolizing Enzymes , 2009, Molecular Pharmacology.

[18]  Peter Antal,et al.  A Bayesian View of Challenges in Feature Selection: Feature Aggregation, Multiple Targets, Redundancy and Interaction , 2008, FSDM.

[19]  F. Harrell,et al.  Evaluating the yield of medical tests. , 1982, JAMA.

[20]  P. Grambsch,et al.  A Package for Survival Analysis in S , 1994 .

[21]  A. Falus,et al.  Roles of Genetic Polymorphisms in the Folate Pathway in Childhood Acute Lymphoblastic Leukemia Evaluated by Bayesian Relevance and Effect Size Analysis , 2013, PloS one.

[22]  V. Haufroid,et al.  A new functional CYP3A4 intron 6 polymorphism significantly affects tacrolimus pharmacokinetics in kidney transplant recipients. , 2011, Clinical chemistry.

[23]  A. Falus,et al.  Bayesian, Systems-based, Multilevel Analysis of Associations for Complex Phenotypes: from Interpretation to Decision , 2014 .

[24]  P. Grambsch,et al.  Modeling Survival Data: Extending the Cox Model , 2000 .

[25]  Hemant Ishwaran,et al.  Evaluating Random Forests for Survival Analysis using Prediction Error Curves. , 2012, Journal of statistical software.

[26]  I. Janszky,et al.  Synergistic interaction of ABCB1 and ABCG2 polymorphisms predicts the prevalence of toxic encephalopathy during anticancer chemotherapy , 2008, The Pharmacogenomics Journal.

[27]  W. Sadee,et al.  Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs , 2011, The Pharmacogenomics Journal.

[28]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[29]  V. Haufroid,et al.  CYP3A4*22: promising newly identified CYP3A4 variant allele for personalizing pharmacotherapy. , 2013, Pharmacogenomics.

[30]  Peter Antal,et al.  Evaluation of a Bayesian model-based approach in GA studies , 2009, MLSB.

[31]  Göran Roos,et al.  Promoter DNA Methylation Pattern Identifies Prognostic Subgroups in Childhood T-Cell Acute Lymphoblastic Leukemia , 2013, PloS one.

[32]  Hajnalka Andrikovics,et al.  Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. , 2008, Leukemia research.